Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Cancer Research - United States
doi 10.1158/0008-5472.can-13-1825
Full Text
Open PDFAbstract
Available in full text
Date
October 11, 2013
Authors
Publisher
American Association for Cancer Research (AACR)